 | • レポートコード：MRC2-11QY08695 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はパンヘプリンのグローバル市場について調査・分析したレポートです。種類別（経口タイプ、注射タイプ）市場規模、用途別（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別パンヘプリンの競争状況、市場シェア ・世界のパンヘプリン市場：種類別市場規模 2015年-2020年（経口タイプ、注射タイプ） ・世界のパンヘプリン市場：種類別市場規模予測 2021年-2026年（経口タイプ、注射タイプ） ・世界のパンヘプリン市場：用途別市場規模 2015年-2020年（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動） ・世界のパンヘプリン市場：用途別市場規模予測 2021年-2026年（静脈血栓塞栓症治療、妊娠合併症、心房細動/粗動電気的除細動） ・北米のパンヘプリン市場分析：米国、カナダ ・ヨーロッパのパンヘプリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのパンヘプリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のパンヘプリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのパンヘプリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Shenzhen Hepalink、Bioiberica、Nanjing King-friend、Pfizer、SPL、Dongcheng Biochemicals、Changzhou Qianhong Bio-pharma、Changshan Biochemical、Pharma Action、Baxter、Dongying Tiandong Pharmaceutical、Opocrin、Aspen Oss、Xinbai Pharmaceuticals、Yino Pharma Limited、Sichuan Deebio ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Panheprin Market
The global Panheprin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Panheprin Scope and Market Size
Panheprin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Panheprin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Panheprin market is segmented into
Oral Type
Injection Type
Segment by Application, the Panheprin market is segmented into
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Regional and Country-level Analysis
The Panheprin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Panheprin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Panheprin Market Share Analysis
Panheprin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Panheprin business, the date to enter into the Panheprin market, Panheprin product introduction, recent developments, etc.
The major vendors covered:
Shenzhen Hepalink
Bioiberica
Nanjing King-friend
Pfizer
SPL
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Pharma Action
Baxter
Dongying Tiandong Pharmaceutical
Opocrin
Aspen Oss
Xinbai Pharmaceuticals
Yino Pharma Limited
Sichuan Deebio
1 Study Coverage
1.1 Panheprin Product Introduction
1.2 Market Segments
1.3 Key Panheprin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Panheprin Market Size Growth Rate by Type
1.4.2 Oral Type
1.4.3 Injection Type
1.5 Market by Application
1.5.1 Global Panheprin Market Size Growth Rate by Application
1.5.2 Treatment of Venous Thromboembolism
1.5.3 Complications of Pregnancy
1.5.4 Cardioversion of Atrial Fibrillation/Flutter
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Panheprin Market Size, Estimates and Forecasts
2.1.1 Global Panheprin Revenue 2015-2026
2.1.2 Global Panheprin Sales 2015-2026
2.2 Global Panheprin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Panheprin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Panheprin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Panheprin Competitor Landscape by Players
3.1 Panheprin Sales by Manufacturers
3.1.1 Panheprin Sales by Manufacturers (2015-2020)
3.1.2 Panheprin Sales Market Share by Manufacturers (2015-2020)
3.2 Panheprin Revenue by Manufacturers
3.2.1 Panheprin Revenue by Manufacturers (2015-2020)
3.2.2 Panheprin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Panheprin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Panheprin Revenue in 2019
3.2.5 Global Panheprin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Panheprin Price by Manufacturers
3.4 Panheprin Manufacturing Base Distribution, Product Types
3.4.1 Panheprin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Panheprin Product Type
3.4.3 Date of International Manufacturers Enter into Panheprin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Panheprin Market Size by Type (2015-2020)
4.1.1 Global Panheprin Sales by Type (2015-2020)
4.1.2 Global Panheprin Revenue by Type (2015-2020)
4.1.3 Panheprin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Panheprin Market Size Forecast by Type (2021-2026)
4.2.1 Global Panheprin Sales Forecast by Type (2021-2026)
4.2.2 Global Panheprin Revenue Forecast by Type (2021-2026)
4.2.3 Panheprin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Panheprin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Panheprin Market Size by Application (2015-2020)
5.1.1 Global Panheprin Sales by Application (2015-2020)
5.1.2 Global Panheprin Revenue by Application (2015-2020)
5.1.3 Panheprin Price by Application (2015-2020)
5.2 Panheprin Market Size Forecast by Application (2021-2026)
5.2.1 Global Panheprin Sales Forecast by Application (2021-2026)
5.2.2 Global Panheprin Revenue Forecast by Application (2021-2026)
5.2.3 Global Panheprin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Panheprin by Country
6.1.1 North America Panheprin Sales by Country
6.1.2 North America Panheprin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Panheprin Market Facts & Figures by Type
6.3 North America Panheprin Market Facts & Figures by Application
7 Europe
7.1 Europe Panheprin by Country
7.1.1 Europe Panheprin Sales by Country
7.1.2 Europe Panheprin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Panheprin Market Facts & Figures by Type
7.3 Europe Panheprin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Panheprin by Region
8.1.1 Asia Pacific Panheprin Sales by Region
8.1.2 Asia Pacific Panheprin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Panheprin Market Facts & Figures by Type
8.3 Asia Pacific Panheprin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Panheprin by Country
9.1.1 Latin America Panheprin Sales by Country
9.1.2 Latin America Panheprin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Panheprin Market Facts & Figures by Type
9.3 Central & South America Panheprin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Panheprin by Country
10.1.1 Middle East and Africa Panheprin Sales by Country
10.1.2 Middle East and Africa Panheprin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Panheprin Market Facts & Figures by Type
10.3 Middle East and Africa Panheprin Market Facts & Figures by Application
11 Company Profiles
11.1 Shenzhen Hepalink
11.1.1 Shenzhen Hepalink Corporation Information
11.1.2 Shenzhen Hepalink Description and Business Overview
11.1.3 Shenzhen Hepalink Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shenzhen Hepalink Panheprin Products Offered
11.1.5 Shenzhen Hepalink Related Developments
11.2 Bioiberica
11.2.1 Bioiberica Corporation Information
11.2.2 Bioiberica Description and Business Overview
11.2.3 Bioiberica Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bioiberica Panheprin Products Offered
11.2.5 Bioiberica Related Developments
11.3 Nanjing King-friend
11.3.1 Nanjing King-friend Corporation Information
11.3.2 Nanjing King-friend Description and Business Overview
11.3.3 Nanjing King-friend Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Nanjing King-friend Panheprin Products Offered
11.3.5 Nanjing King-friend Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Panheprin Products Offered
11.4.5 Pfizer Related Developments
11.5 SPL
11.5.1 SPL Corporation Information
11.5.2 SPL Description and Business Overview
11.5.3 SPL Sales, Revenue and Gross Margin (2015-2020)
11.5.4 SPL Panheprin Products Offered
11.5.5 SPL Related Developments
11.6 Dongcheng Biochemicals
11.6.1 Dongcheng Biochemicals Corporation Information
11.6.2 Dongcheng Biochemicals Description and Business Overview
11.6.3 Dongcheng Biochemicals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dongcheng Biochemicals Panheprin Products Offered
11.6.5 Dongcheng Biochemicals Related Developments
11.7 Changzhou Qianhong Bio-pharma
11.7.1 Changzhou Qianhong Bio-pharma Corporation Information
11.7.2 Changzhou Qianhong Bio-pharma Description and Business Overview
11.7.3 Changzhou Qianhong Bio-pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Changzhou Qianhong Bio-pharma Panheprin Products Offered
11.7.5 Changzhou Qianhong Bio-pharma Related Developments
11.8 Changshan Biochemical
11.8.1 Changshan Biochemical Corporation Information
11.8.2 Changshan Biochemical Description and Business Overview
11.8.3 Changshan Biochemical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Changshan Biochemical Panheprin Products Offered
11.8.5 Changshan Biochemical Related Developments
11.9 Pharma Action
11.9.1 Pharma Action Corporation Information
11.9.2 Pharma Action Description and Business Overview
11.9.3 Pharma Action Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pharma Action Panheprin Products Offered
11.9.5 Pharma Action Related Developments
11.10 Baxter
11.10.1 Baxter Corporation Information
11.10.2 Baxter Description and Business Overview
11.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Baxter Panheprin Products Offered
11.10.5 Baxter Related Developments
11.1 Shenzhen Hepalink
11.1.1 Shenzhen Hepalink Corporation Information
11.1.2 Shenzhen Hepalink Description and Business Overview
11.1.3 Shenzhen Hepalink Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shenzhen Hepalink Panheprin Products Offered
11.1.5 Shenzhen Hepalink Related Developments
11.12 Opocrin
11.12.1 Opocrin Corporation Information
11.12.2 Opocrin Description and Business Overview
11.12.3 Opocrin Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Opocrin Products Offered
11.12.5 Opocrin Related Developments
11.13 Aspen Oss
11.13.1 Aspen Oss Corporation Information
11.13.2 Aspen Oss Description and Business Overview
11.13.3 Aspen Oss Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Aspen Oss Products Offered
11.13.5 Aspen Oss Related Developments
11.14 Xinbai Pharmaceuticals
11.14.1 Xinbai Pharmaceuticals Corporation Information
11.14.2 Xinbai Pharmaceuticals Description and Business Overview
11.14.3 Xinbai Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Xinbai Pharmaceuticals Products Offered
11.14.5 Xinbai Pharmaceuticals Related Developments
11.15 Yino Pharma Limited
11.15.1 Yino Pharma Limited Corporation Information
11.15.2 Yino Pharma Limited Description and Business Overview
11.15.3 Yino Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Yino Pharma Limited Products Offered
11.15.5 Yino Pharma Limited Related Developments
11.16 Sichuan Deebio
11.16.1 Sichuan Deebio Corporation Information
11.16.2 Sichuan Deebio Description and Business Overview
11.16.3 Sichuan Deebio Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sichuan Deebio Products Offered
11.16.5 Sichuan Deebio Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Panheprin Market Estimates and Projections by Region
12.1.1 Global Panheprin Sales Forecast by Regions 2021-2026
12.1.2 Global Panheprin Revenue Forecast by Regions 2021-2026
12.2 North America Panheprin Market Size Forecast (2021-2026)
12.2.1 North America: Panheprin Sales Forecast (2021-2026)
12.2.2 North America: Panheprin Revenue Forecast (2021-2026)
12.2.3 North America: Panheprin Market Size Forecast by Country (2021-2026)
12.3 Europe Panheprin Market Size Forecast (2021-2026)
12.3.1 Europe: Panheprin Sales Forecast (2021-2026)
12.3.2 Europe: Panheprin Revenue Forecast (2021-2026)
12.3.3 Europe: Panheprin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Panheprin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Panheprin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Panheprin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Panheprin Market Size Forecast by Region (2021-2026)
12.5 Latin America Panheprin Market Size Forecast (2021-2026)
12.5.1 Latin America: Panheprin Sales Forecast (2021-2026)
12.5.2 Latin America: Panheprin Revenue Forecast (2021-2026)
12.5.3 Latin America: Panheprin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Panheprin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Panheprin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Panheprin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Panheprin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Panheprin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Panheprin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Panheprin Market Segments
Table 2. Ranking of Global Top Panheprin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Panheprin Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral Type
Table 5. Major Manufacturers of Injection Type
Table 6. Global Panheprin Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Panheprin Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Panheprin Sales by Regions 2015-2020 (K Units)
Table 9. Global Panheprin Sales Market Share by Regions (2015-2020)
Table 10. Global Panheprin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Panheprin Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Panheprin Sales Share by Manufacturers (2015-2020)
Table 13. Global Panheprin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Panheprin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Panheprin as of 2019)
Table 15. Panheprin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Panheprin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Panheprin Price (2015-2020) (USD/Unit)
Table 18. Panheprin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Panheprin Product Type
Table 20. Date of International Manufacturers Enter into Panheprin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Panheprin Sales by Type (2015-2020) (K Units)
Table 23. Global Panheprin Sales Share by Type (2015-2020)
Table 24. Global Panheprin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Panheprin Revenue Share by Type (2015-2020)
Table 26. Panheprin Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Panheprin Sales by Application (2015-2020) (K Units)
Table 28. Global Panheprin Sales Share by Application (2015-2020)
Table 29. North America Panheprin Sales by Country (2015-2020) (K Units)
Table 30. North America Panheprin Sales Market Share by Country (2015-2020)
Table 31. North America Panheprin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Panheprin Revenue Market Share by Country (2015-2020)
Table 33. North America Panheprin Sales by Type (2015-2020) (K Units)
Table 34. North America Panheprin Sales Market Share by Type (2015-2020)
Table 35. North America Panheprin Sales by Application (2015-2020) (K Units)
Table 36. North America Panheprin Sales Market Share by Application (2015-2020)
Table 37. Europe Panheprin Sales by Country (2015-2020) (K Units)
Table 38. Europe Panheprin Sales Market Share by Country (2015-2020)
Table 39. Europe Panheprin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Panheprin Revenue Market Share by Country (2015-2020)
Table 41. Europe Panheprin Sales by Type (2015-2020) (K Units)
Table 42. Europe Panheprin Sales Market Share by Type (2015-2020)
Table 43. Europe Panheprin Sales by Application (2015-2020) (K Units)
Table 44. Europe Panheprin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Panheprin Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Panheprin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Panheprin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Panheprin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Panheprin Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Panheprin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Panheprin Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Panheprin Sales Market Share by Application (2015-2020)
Table 53. Latin America Panheprin Sales by Country (2015-2020) (K Units)
Table 54. Latin America Panheprin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Panheprin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Panheprin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Panheprin Sales by Type (2015-2020) (K Units)
Table 58. Latin America Panheprin Sales Market Share by Type (2015-2020)
Table 59. Latin America Panheprin Sales by Application (2015-2020) (K Units)
Table 60. Latin America Panheprin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Panheprin Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Panheprin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Panheprin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Panheprin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Panheprin Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Panheprin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Panheprin Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Panheprin Sales Market Share by Application (2015-2020)
Table 69. Shenzhen Hepalink Corporation Information
Table 70. Shenzhen Hepalink Description and Major Businesses
Table 71. Shenzhen Hepalink Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Shenzhen Hepalink Product
Table 73. Shenzhen Hepalink Recent Development
Table 74. Bioiberica Corporation Information
Table 75. Bioiberica Description and Major Businesses
Table 76. Bioiberica Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bioiberica Product
Table 78. Bioiberica Recent Development
Table 79. Nanjing King-friend Corporation Information
Table 80. Nanjing King-friend Description and Major Businesses
Table 81. Nanjing King-friend Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Nanjing King-friend Product
Table 83. Nanjing King-friend Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Major Businesses
Table 86. Pfizer Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. SPL Corporation Information
Table 90. SPL Description and Major Businesses
Table 91. SPL Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. SPL Product
Table 93. SPL Recent Development
Table 94. Dongcheng Biochemicals Corporation Information
Table 95. Dongcheng Biochemicals Description and Major Businesses
Table 96. Dongcheng Biochemicals Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Dongcheng Biochemicals Product
Table 98. Dongcheng Biochemicals Recent Development
Table 99. Changzhou Qianhong Bio-pharma Corporation Information
Table 100. Changzhou Qianhong Bio-pharma Description and Major Businesses
Table 101. Changzhou Qianhong Bio-pharma Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Changzhou Qianhong Bio-pharma Product
Table 103. Changzhou Qianhong Bio-pharma Recent Development
Table 104. Changshan Biochemical Corporation Information
Table 105. Changshan Biochemical Description and Major Businesses
Table 106. Changshan Biochemical Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Changshan Biochemical Product
Table 108. Changshan Biochemical Recent Development
Table 109. Pharma Action Corporation Information
Table 110. Pharma Action Description and Major Businesses
Table 111. Pharma Action Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Pharma Action Product
Table 113. Pharma Action Recent Development
Table 114. Baxter Corporation Information
Table 115. Baxter Description and Major Businesses
Table 116. Baxter Panheprin Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Baxter Product
Table 118. Baxter Recent Development
Table 119. Dongying Tiandong Pharmaceutical Corporation Information
Table 120. Dongying Tiandong Pharmaceutical Description and Major Businesses
Table 121. Dongying Tiandong Pharmaceutical Panheprin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Dongying Tiandong Pharmaceutical Product
Table 123. Dongying Tiandong Pharmaceutical Recent Development
Table 124. Opocrin Corporation Information
Table 125. Opocrin Description and Major Businesses
Table 126. Opocrin Panheprin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Opocrin Product
Table 128. Opocrin Recent Development
Table 129. Aspen Oss Corporation Information
Table 130. Aspen Oss Description and Major Businesses
Table 131. Aspen Oss Panheprin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Aspen Oss Product
Table 133. Aspen Oss Recent Development
Table 134. Xinbai Pharmaceuticals Corporation Information
Table 135. Xinbai Pharmaceuticals Description and Major Businesses
Table 136. Xinbai Pharmaceuticals Panheprin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Xinbai Pharmaceuticals Product
Table 138. Xinbai Pharmaceuticals Recent Development
Table 139. Yino Pharma Limited Corporation Information
Table 140. Yino Pharma Limited Description and Major Businesses
Table 141. Yino Pharma Limited Panheprin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Yino Pharma Limited Product
Table 143. Yino Pharma Limited Recent Development
Table 144. Sichuan Deebio Corporation Information
Table 145. Sichuan Deebio Description and Major Businesses
Table 146. Sichuan Deebio Panheprin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Sichuan Deebio Product
Table 148. Sichuan Deebio Recent Development
Table 149. Global Panheprin Sales Forecast by Regions (2021-2026) (K Units)
Table 150. Global Panheprin Sales Market Share Forecast by Regions (2021-2026)
Table 151. Global Panheprin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 152. Global Panheprin Revenue Market Share Forecast by Regions (2021-2026)
Table 153. North America: Panheprin Sales Forecast by Country (2021-2026) (K Units)
Table 154. North America: Panheprin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Europe: Panheprin Sales Forecast by Country (2021-2026) (K Units)
Table 156. Europe: Panheprin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Asia Pacific: Panheprin Sales Forecast by Region (2021-2026) (K Units)
Table 158. Asia Pacific: Panheprin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Latin America: Panheprin Sales Forecast by Country (2021-2026) (K Units)
Table 160. Latin America: Panheprin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Middle East and Africa: Panheprin Sales Forecast by Country (2021-2026) (K Units)
Table 162. Middle East and Africa: Panheprin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 164. Key Challenges
Table 165. Market Risks
Table 166. Main Points Interviewed from Key Panheprin Players
Table 167. Panheprin Customers List
Table 168. Panheprin Distributors List
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Panheprin Product Picture
Figure 2. Global Panheprin Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Type Product Picture
Figure 4. Injection Type Product Picture
Figure 5. Global Panheprin Sales Market Share by Application in 2020 & 2026
Figure 6. Treatment of Venous Thromboembolism
Figure 7. Complications of Pregnancy
Figure 8. Cardioversion of Atrial Fibrillation/Flutter
Figure 9. Panheprin Report Years Considered
Figure 10. Global Panheprin Market Size 2015-2026 (US$ Million)
Figure 11. Global Panheprin Sales 2015-2026 (K Units)
Figure 12. Global Panheprin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Panheprin Sales Market Share by Region (2015-2020)
Figure 14. Global Panheprin Sales Market Share by Region in 2019
Figure 15. Global Panheprin Revenue Market Share by Region (2015-2020)
Figure 16. Global Panheprin Revenue Market Share by Region in 2019
Figure 17. Global Panheprin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Panheprin Revenue in 2019
Figure 19. Panheprin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Panheprin Sales Market Share by Type (2015-2020)
Figure 21. Global Panheprin Sales Market Share by Type in 2019
Figure 22. Global Panheprin Revenue Market Share by Type (2015-2020)
Figure 23. Global Panheprin Revenue Market Share by Type in 2019
Figure 24. Global Panheprin Market Share by Price Range (2015-2020)
Figure 25. Global Panheprin Sales Market Share by Application (2015-2020)
Figure 26. Global Panheprin Sales Market Share by Application in 2019
Figure 27. Global Panheprin Revenue Market Share by Application (2015-2020)
Figure 28. Global Panheprin Revenue Market Share by Application in 2019
Figure 29. North America Panheprin Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Panheprin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Panheprin Sales Market Share by Country in 2019
Figure 32. North America Panheprin Revenue Market Share by Country in 2019
Figure 33. U.S. Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Panheprin Market Share by Type in 2019
Figure 38. North America Panheprin Market Share by Application in 2019
Figure 39. Europe Panheprin Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Panheprin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Panheprin Sales Market Share by Country in 2019
Figure 42. Europe Panheprin Revenue Market Share by Country in 2019
Figure 43. Germany Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Panheprin Market Share by Type in 2019
Figure 54. Europe Panheprin Market Share by Application in 2019
Figure 55. Asia Pacific Panheprin Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Panheprin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Panheprin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Panheprin Revenue Market Share by Region in 2019
Figure 59. China Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Panheprin Market Share by Type in 2019
Figure 82. Asia Pacific Panheprin Market Share by Application in 2019
Figure 83. Latin America Panheprin Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Panheprin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Panheprin Sales Market Share by Country in 2019
Figure 86. Latin America Panheprin Revenue Market Share by Country in 2019
Figure 87. Mexico Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Panheprin Market Share by Type in 2019
Figure 94. Latin America Panheprin Market Share by Application in 2019
Figure 95. Middle East and Africa Panheprin Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Panheprin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Panheprin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Panheprin Revenue Market Share by Country in 2019
Figure 99. Turkey Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Panheprin Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Panheprin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Panheprin Market Share by Type in 2019
Figure 106. Middle East and Africa Panheprin Market Share by Application in 2019
Figure 107. North America Panheprin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Panheprin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Panheprin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Panheprin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Panheprin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Panheprin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Panheprin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Panheprin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Panheprin Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Panheprin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
心房細動（SPAF）治療における脳卒中予防の世界市場（～2026年） Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. Market Analysis and Ins…- 心房細動（AF）治療の世界市場（～2026年） Atrial fibrillation is an abnormal heart rhythm characterized by rapid and irregular beating of the atria. Often it starts as brief periods of abnormal beating which become longer and possibly constant over time. Often episodes have no symptoms. Occasionally there may be heart palpitations, fainting…
- 静脈血栓塞栓症（VTE）治療薬の世界市場（～2026年） Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot tha…
- 心房細動（AF）診断の世界市場（～2026年） Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but most common ones associated with it are fainting, palpitations, congestive failure of the heart or chest pain. Factors such as aging of populati…
- 静脈血栓塞栓症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Venous Thromboembolism Therapeutics Drugs Market The global Venous Thromboembolism Therapeutics Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Venous Thromboembolism Therapeu…